National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
NCI Drug Dictionary

rhizoxin
A macrocyclic lactone. Rhizoxin binds to tubulin and inhibits microtubule assembly, thereby inducing cytotoxicity. This agent also may inhibit endothelial cell-induced angiogenic activity, which may result in decreased tumor cell proliferation. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Code name:WF-1360

Previous:REXIN-G, rexinoid NRX194204, Rezulin, RFT5-dgA immunotoxin, rhEndostatin
Next:ribavirin, riboflavin, ribosome-inactivating protein CY503, Riboxamide, rifabutin